Indication
AIDS with Kaposi's sarcoma
AIDS with Kaposi's sarcoma refers to an epidemic, multicentric angioproliferative neoplasm that serves as an AIDS-defining condition in individuals with advanced human immunodeficiency virus (HIV) infection. Read more about AIDS with Kaposi's sarcoma
22 drugs 11 manufacturers
Drugs that treat it
Common AIDS with Kaposi's sarcoma therapies.
DOXORUBICIN HCL LIPOSOME (doxorubicin HCl pegylated liposomal)
DOXORUBICIN HCL LIPOSOME (doxorubicin HCl pegylated liposomal)
DOXORUBICIN HCL LIPOSOME (doxorubicin HCl pegylated liposomal)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAIDS with Kaposi's sarcoma refers to an epidemic, multicentric angioproliferative neoplasm that serves as an AIDS-defining condition in individuals with advanced human immunodeficiency virus (HIV) infection.
Driven by co-infection with human herpesvirus 8 (HHV-8/KSHV) alongside HIV-induced immunosuppression and cytokine dysregulation, it primarily targets vascular and lymphatic endothelial cells.
Clinically, it presents as characteristic red, purple, or brown macules, plaques, or nodules on the skin and mucous membranes, frequently accompanied by lymphedema.
It may also progress aggressively to involve extracutaneous sites, notably the lymph nodes, gastrointestinal tract, and pulmonary parenchyma.
- nih.gov
AIDS with Kaposi's sarcoma refers to an epidemic, multicentric angioproliferative neoplasm that serves as an AIDS-defining condition in individuals with advanced human immunodeficiency virus (HIV) infection Driven by co-infection with human herpesvirus 8 (HHV-8/KSHV) alongside HIV-induced immunosuppression and cytokine dysregulation, it primarily targets vascular and lymphatic endothelial cells
- nih.gov
AIDS with Kaposi's sarcoma refers to an epidemic, multicentric angioproliferative neoplasm that serves as an AIDS-defining condition in individuals with advanced human immunodeficiency virus (HIV) infection Driven by co-infection with human herpesvirus 8 (HHV-8/KSHV) alongside HIV-induced immunosuppression and cytokine dysregulation, it primarily targets vascular and lymphatic endothelial cells Clinically, it presents as characteristic red, purple, or brown macules, plaques, or nodules on the sk...
- hiv.gov
AIDS with Kaposi's sarcoma refers to an epidemic, multicentric angioproliferative neoplasm that serves as an AIDS-defining condition in individuals with advanced human immunodeficiency virus (HIV) infection
- aids.gov.hk
Driven by co-infection with human herpesvirus 8 (HHV-8/KSHV) alongside HIV-induced immunosuppression and cytokine dysregulation, it primarily targets vascular and lymphatic endothelial cells
- mayoclinic.org
Clinically, it presents as characteristic red, purple, or brown macules, plaques, or nodules on the skin and mucous membranes, frequently accompanied by lymphedema
- nih.gov
It may also progress aggressively to involve extracutaneous sites, notably the lymph nodes, gastrointestinal tract, and pulmonary parenchyma
- hopkinsmedicine.org
It may also progress aggressively to involve extracutaneous sites, notably the lymph nodes, gastrointestinal tract, and pulmonary parenchyma
Personalize your experience
Follow AIDS with Kaposi's sarcoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.